Perceived threat of COVID-19, attitudes towards vaccination, and vaccine hesitancy: A prospective longitudinal study in the UK
preprintposted on 20.09.2021, 08:48 by Rhiannon PhillipsRhiannon Phillips, David Gillespie, Britt HallingbergBritt Hallingberg, Jennifer Evans, Khadijeh Taiyari, Anna Torrens-Burton, Rebecca Cannings-John, Denitza Williams, Elizabeth Sheils, Pauline Ashfield-Watt, Kathryn Hughes, Emma Thomas-Jones, Delyth JamesDelyth James, Fiona Wood
Pre-print of article. Please note that this version has not been peer-reviewed, and is currently with a journal for consideration.
Using the Health Belief Model as a conceptual framework, we investigated the association between attitudes towards COVID-19, COVID-19 vaccinations, and vaccine hesitancy and change in these variables over a 9-month period in a UK cohort.
The COPE study cohort (n=11,113) were recruited via and online survey at enrolment March/April 2020. The study was advertised via the HealthWise Wales research registry and social media. Follow-up data were available for 6,942 people at 3-months (June/July 2020) and 5,037 at 12-months (March/April 2021) post-enrolment. Measures included demographics, perceived threat of COVID-19, self-efficacy, intention to accept or decline a COVID-19 vaccination, and attitudes towards vaccination. Logistic regression models were fitted cross-sectionally at 3- and 12-months to assess the association between motivational factors and vaccine hesitancy. Longitudinal change in motivational variables for vaccine-hesitant and non-hesitant groups were examined using mixed-effect ANOVA models.
Fear of COVID-19, perceived susceptibility to COVID-19 and perceived personal control over COVID-19 infection transmission decreased between the 3- and 12-month surveys.
Vaccine hesitancy at 12-months was independently associated with low fear of the disease and more negative attitudes towards COVID-19 vaccination. Specific barriers to COVID-19 vaccine uptake included concerns about safety and efficacy in light of its rapid development, mistrust of government and pharmaceutical companies, dislike of coercive policies, and perceived lack of relaxation in COVID-19 related restrictions as the vaccination program progressed.
Decreasing fear of COVID-19, perceived susceptibility to the disease, and perceptions of personal control over reducing infection-transmission may impact on future COVID-19 vaccination uptake.